Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.

[1]  W. Curran,et al.  A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617. , 2013 .

[2]  George Iliakis,et al.  DNA Double-Strand Break Repair as Determinant of Cellular Radiosensitivity to Killing and Target in Radiation Therapy , 2013, Front. Oncol..

[3]  P. Crooks,et al.  The Novel Chemical Entity YTR107 Inhibits Recruitment of Nucleophosmin to Sites of DNA Damage, Suppressing Repair of DNA Double-Strand Breaks and Enhancing Radiosensitization , 2011, Clinical Cancer Research.

[4]  N. Socci,et al.  Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling , 2011, Science Translational Medicine.

[5]  R. Kanaar,et al.  Regulation of DNA strand exchange in homologous recombination. , 2010, DNA repair.

[6]  Y. Okada,et al.  Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates. , 2010, Cancer research.

[7]  Ji Luo,et al.  Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.

[8]  黄亚明.  MedScape , 2009 .

[9]  David N. Boone,et al.  Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation , 2008, Proceedings of the National Academy of Sciences.

[10]  W. Qi,et al.  NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells , 2008, Oncogene.

[11]  Seung-Oe Lim,et al.  Crystal structure of human nucleophosmin‐core reveals plasticity of the pentamer–pentamer interface , 2007, Proteins.

[12]  B. Falini,et al.  Nucleophosmin Is Required for DNA Integrity and p19Arf Protein Stability , 2005, Molecular and Cellular Biology.

[13]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[14]  A. Canutescu,et al.  Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth , 2005, Molecular Cancer Therapeutics.

[15]  Jeffrey Bradley,et al.  Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[16]  Stig Johan Wiklund,et al.  Aspects of design and statistical analysis in the Comet assay. , 2003, Mutagenesis.

[17]  T. Helleday,et al.  Different Roles for Nonhomologous End Joining and Homologous Recombination following Replication Arrest in Mammalian Cells , 2002, Molecular and Cellular Biology.

[18]  Pier Giuseppe Pelicci,et al.  Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.

[19]  H. F. Horn,et al.  Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication , 2000, Cell.

[20]  V. Yamazaki,et al.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage , 2000, Current Biology.

[21]  P. Chan,et al.  Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells. , 1995, Biochimica et biophysica acta.

[22]  A. Wambersie,et al.  Introduction to Radiobiology , 1990 .

[23]  J. Venditti,et al.  Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. , 1987, Cancer treatment reports.

[24]  M. Bender,et al.  Radiation-induced cellular reproductive death and chromosome aberrations. , 1978, Radiation research.

[25]  W. Dewey,et al.  Chromosomal aberrations and mortality of x-irradiated mammalian cells: emphasis on repair. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Trevor J Pugh,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[27]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[28]  Melanie M. Choe,et al.  The comet assay: a method to measure DNA damage in individual cells , 2006, Nature Protocols.